Case Report: Biological treatment of epidermolysis bullosa acquisita: report on four cases and literature review. [PDF]
Front Immunol, 2023 Szymański K +3 more
europepmc +1 more source
Refractory Epidermolysis Bullosa Acquisita with Chronic Graft-versus-Host Disease Successfully Treated with Rituximab. [PDF]
Ann Dermatol, 2023 Han JH +5 more
europepmc +1 more source
Risk factors and sequelae of epidermolysis bullosa acquisita: A propensity-matched global study in 1,344 patients. [PDF]
Front Immunol, 2022 Kridin K +5 more
europepmc +1 more source
Epidermolysis bullosa acquisita treated with rituximab. [PDF]
BMJ Case Rep, 2021 Mendes SR, Coutinho I, Cardoso JC.
europepmc +1 more source
The complement receptor C5aR2 regulates neutrophil activation and function contributing to neutrophil-driven epidermolysis bullosa acquisita. [PDF]
Front Immunol, 2023 Seiler DL +7 more
europepmc +1 more source
Epidermolysis Bullosa Acquisita [PDF]
Proceedings of the Royal Society of Medicine, 1948 openaire +2 more sources
Mixed IgM- and IgA-mediated epidermolysis bullosa acquisita associated with IgM-λ paraproteinemia in an 81-year-old woman. [PDF]
JAAD Case Rep, 2023 Chau T +7 more
europepmc +1 more source
Case report: A case of epidermolysis bullosa acquisita with IgG and IgM anti-basement membrane zone antibodies relapsed after COVID-19 mRNA vaccination. [PDF]
Front Med (Lausanne), 2023 Minakawa S +8 more
europepmc +1 more source
Vesiculobullous Erythema Elevatum Diutinum: a Rare Variant With Epidermolysis Bullosa Acquisita-like Immunofluorescence Findings. [PDF]
Dermatol Pract Concept, 2022 Yalici-Armagan B +3 more
europepmc +1 more source
Epidermolysis bullosa acquisita: an uncommon cause of esophageal stricture. [PDF]
Oxf Med Case Reports, 2021 Figueredo C, Boroda K, Hertan H.
europepmc +1 more source